Use of the Long-acting Hematopoietic Growth Factors Pegfilgrastim and Darbepoetin Alfa in Support of Dose-Dense Adjuvant Chemotherapy
Burstein HJ, Parker LM, Doherty J, Partridge AH, Schapira L, Ryan PD, Younger J, Harris LN, Moy B, Bunnell CA, Come S, Schumer S, Haldoupis M, Gelman R, Winer EP. Use of the Long-acting Hematopoietic Growth Factors Pegfilgrastim and Darbepoetin Alfa in Support of Dose-Dense Adjuvant Chemotherapy. San Antonio Breast Cancer Symposium. 2004.